Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
75.5M
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
3.01M
-
Shares change
-
+1.54M
-
Total reported value, excl. options
-
$3.85M
-
Value change
-
+$1.97M
-
Number of buys
-
13
-
Number of sells
-
-6
-
Price
-
$1.28
Significant Holders of Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) as of Q2 2020
25 filings reported holding CLRB - Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share as of Q2 2020.
Cellectar Biosciences, Inc. - Common Stock, $0.00001 par value per share (CLRB) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.01M shares
of 75.5M outstanding shares and own 3.98% of the company stock.
Largest 10 shareholders include BOXER CAPITAL, LLC (920K shares), RENAISSANCE TECHNOLOGIES LLC (791K shares), Worth Venture Partners, LLC (399K shares), Sio Capital Management, LLC (189K shares), CVI Holdings, LLC (140K shares), Quilter Plc (137K shares), FNY Investment Advisers, LLC (128K shares), SPHERA FUNDS MANAGEMENT LTD. (87.5K shares), TWO SIGMA ADVISERS, LP (55.3K shares), and WEDBUSH SECURITIES INC (40.3K shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.